Multimodal Deep Learning for Prediction of Progression-Free Survival in Patients with Neuroendocrine Tumors Undergoing 177Lu-based Peptide Receptor Radionuclide Therapy. - Simon Baur; Tristan Ruhwedel; Ekin Böke; Zuzanna Kobus; Gergana Lishkova; Christoph Wetz; Holger Amthauer; Christoph Roderburg; Frank Tacke; Julian M. Rogasch; Wojciech Samek; Henning Jann; et al. (CoRR, 2025)